Drug Recall: Altaire Pharmaceuticals Eye Drops
By: Chelsea Slyker, PharmD, MPH

Altaire Pharmaceuticals recently announced a voluntary recall on a number of over-the-counter eye drops. The company manufactures a number of different eye drop formulations, which are sold under different names as store-brand generics. This particular recall affects eye drops sold at Walgreens, Walmart, and CVS, and the products may be sold under a few different brand names. The recall is limited to a set of specific lot numbers that can be found on the bottles.

Please see the links below for all recalled products and lot numbers to see if you are affected by the recall.

For drops sold at CVS:
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-sold-cvs

For drops sold at Walgreens
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products-sold-walgreens

Drug Recall Eye Drops

Drug Recall Eye Drops

compare prices at pharmacies, save up to 80% with easy drug card

To view a complete list of recalled brands names and lot numbers, visit the FDA website:

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

While there have been no reports of adverse events as a result of using this brand of eye drops, there may be a lack of sterility. Altaire announced the recall because of concerns with quality controls within a manufacturing facility, meaning some products sold by the company may not meet FDA sterility standards.

The affected products date back to 2017, so it is important to check your medicine cabinet for any of these products that may have been purchased in the last two years. Any adverse events should be reported to the FDA either by phone or online.

Dr. Chelsea Slyker

About Dr. Chelsea Slyker

Dr. Chelsea Slyker received her Doctorate of Pharmacy from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and her Master of Public Health from the Colorado School of Public Health. Her interests include addiction medicine, behavioral health, and healthcare policy. She looks forward to combining her clinical pharmacy background with her passion for public health to improve access to affordable health care.